Protaryx Medical Achieves Milestone with Successful Completion of First-in-Human Study of an Innovative Transseptal Puncture Technology

By Protaryx | December 11, 2024 |

Baltimore, Maryland – December 11, 2024 – Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative potential of its advanced transseptal puncture technology. Conducted on December 3, 2024, at Sanatorio Italiano de Asunción in Paraguay, the study enrolled five patients under…

Read More